Want to see IN:INDGN full AI Analyst Report?

Indegene Limited (INDGN) Price & Analysis

4 Followers

INDGN Stock Chart & Stats

₹569.65

₹15.40(3.13%)

At close: Jul 27 4:00 PM EDT

₹569.65

₹15.40(3.13%)

Day’s Range― - ―

52-Week Range₹414.90 - ₹616.00

Previous CloseN/A

Volume165.17K

Average Volume (3M)67.57K

Market Cap

₹138.06B

Enterprise Value₹91.58K

Total Cash (Recent Filing)₹14.81B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)35.4

Beta0.55

Next Earnings

Nov 04, 2026

EPS Estimate

5.2

Next Dividend Ex-DateN/A

Dividend Yield0.38%

Share Statistics

EPS (TTM)16.70

Shares Outstanding240,966,750

10 Day Avg. Volume69,686

30 Day Avg. Volume67,567

Financial Highlights & Ratios

PEG Ratio-10.37

Price to Book (P/B)3.32

Price to Sales (P/S)2.97

P/FCF Ratio16.84

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)23.74

Revenue Forecast (FY)₹44.33B

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSustained revenue expansion indicates continued demand for Indegene's healthcare and life-sciences services. Growth supports operating scale, creates opportunities to expand within client accounts, and provides a durable base for investment in digital, analytics, and managed-service capabilities.

Conservative Balance SheetVery low leverage gives Indegene financial flexibility to fund expansion, absorb variability in client spending, and pursue technology or capability investments without substantial balance-sheet strain. A growing equity base also strengthens resilience as the services platform scales.

Strong Recent Free Cash FlowRecent free-cash-flow performance suggests that reported earnings have generally translated into usable cash. This supports reinvestment, employee and technology development, and other strategic priorities while reducing reliance on external financing to sustain growth.

Bears Say

Volatile Cash ConversionUneven cash conversion makes the timing and reliability of internally generated funds less predictable than headline profitability suggests. If volatility persists, management may have less flexibility to fund growth initiatives or absorb changes in client project and contract timing.

Debt Increased In 2026The rise in total debt introduces a developing balance-sheet consideration even though overall leverage remains low. Continued borrowing could increase financing obligations and reduce flexibility if debt grows faster than earnings, equity, or the cash generated by operations.

Negative EPS GrowthNegative EPS growth indicates that per-share earnings have not kept pace over the measured period, weakening the earnings-growth profile despite strong revenue trends and healthy net income. Persistent pressure could limit the conversion of business expansion into shareholder-level earnings growth.

Indegene Limited News

Indegene Schedules Investor Meetings to Deepen Market Engagement

Indegene Limited ( ($IN:INDGN) ) just unveiled an announcement. Indegene Limited, a Bengaluru-headquartered provider of technology-enabled solutions for...

1M ago

INDGN

Indegene posts 39.7% YoY revenue surge and stronger margins in Q1 FY27

Indegene Limited ( ($IN:INDGN) ) has shared an update. Indegene reported a strong start to FY27, with revenue...

2M ago

INDGN

Indegene Publishes Q1 FY27 Analyst Presentation and Fact Sheet

Indegene Limited ( ($IN:INDGN) ) has provided an announcement. Indegene Limited has released an analyst presentation and fact...

2M ago

INDGN

Indegene posts audio recording of FY26 earnings call for investors

Indegene Limited ( ($IN:INDGN) ) has shared an update. Indegene Limited has notified the stock exchanges that the...

5M ago

INDGN

Indegene to Acquire Two UK Consulting Subsidiaries, Expands Healthcare Services Footprint

Indegene Limited ( ($IN:INDGN) ) has shared an update. Indegene Limited’s wholly owned unit, Indegene Healthcare UK Limited,...

7M ago

INDGN

Indegene Shareholders Approve Appointment of Neeraj Bharadwaj as Independent Director via Postal Ballot

Indegene Limited ( ($IN:INDGN) ) has provided an update. Indegene Limited has announced that its shareholders have approved,...

8M ago

INDGN

Indegene Consolidates Canadian Subsidiaries Into Indegene Healthcare Canada Inc.

Indegene Limited ( ($IN:INDGN) ) has shared an update. Indegene Limited has announced the amalgamation of its two...

9M ago

INDGN

Indegene Appoints Neeraj Bharadwaj as Independent Director, Allots Shares Under ESOP and RSU Plans

Indegene Limited ( ($IN:INDGN) ) has issued an update. Indegene Limited’s board has approved the appointment of Neeraj...

9M ago

INDGN

Indegene Limited Opens Trading Window Post Financial Results

The latest update is out from Indegene Limited ( ($IN:INDGN) ). Indegene Limited has announced the opening of...

11M ago

INDGN

Indegene Limited Announces Strategic Investments and Policy Amendments

Indegene Limited ( ($IN:INDGN) ) has issued an update. Indegene Limited’s board has approved several key initiatives, including...

11M ago

INDGN

INDGN FAQ

What was Indegene Limited’s price range in the past 12 months?

Indegene Limited lowest stock price was ₹414.90 and its highest was ₹616.00 in the past 12 months.

What is Indegene Limited’s market cap?

Indegene Limited’s market cap is ₹138.06B.

When is Indegene Limited’s upcoming earnings report date?

Indegene Limited’s upcoming earnings report date is Nov 04, 2026 which is in 47 days.

How were Indegene Limited’s earnings last quarter?

Indegene Limited released its earnings results on Jul 30, 2026. The company reported ₹4.8 earnings per share for the quarter, beating the consensus estimate of ₹4.633 by ₹0.167.

Is Indegene Limited overvalued?

According to Wall Street analysts Indegene Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Indegene Limited pay dividends?

Indegene Limited pays a Annually dividend of ₹2.25 which represents an annual dividend yield of 0.38%. See more information on Indegene Limited dividends here

What is Indegene Limited’s EPS estimate?

Indegene Limited’s EPS estimate is 5.2.

How many shares outstanding does Indegene Limited have?

Indegene Limited has 240,966,750 shares outstanding.

What happened to Indegene Limited’s price movement after its last earnings report?

Indegene Limited reported an EPS of ₹4.8 in its last earnings report, beating expectations of ₹4.633. Following the earnings report the stock price went down -1.747%.

Which hedge fund is a major shareholder of Indegene Limited?

Currently, no hedge funds are holding shares in IN:INDGN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Indegene Limited

Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.